DL DrugLabelsHubFDA Drug Label Lookup

Novartis Pharmaceuticals Corporation

29 FDA products 28 active ingredients HUMAN PRESCRIPTION DRUG

Novartis Pharmaceuticals Corporation is listed as the manufacturer on 29 FDA drug label records covering 28 distinct active ingredients predominantly human prescription drug products.

About Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation is named as the labeler on 29 FDA drug label records. Its catalogue spans 28 distinct active ingredients, led by CYCLOSPORINE, ATRASENTAN, CANAKINUMAB, CARBAMAZEPINE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: pediatric patients, treatment adult, detected fda-approved, breast cancer, indicated combination, braf mutation, years age, unresectable metastatic. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
CYCLOSPORINE 2
ATRASENTAN 1
CANAKINUMAB 1
CARBAMAZEPINE 1
CLOFAZIMINE 1
CRIZANLIZUMAB 1
DABRAFENIB 1
EVEROLIMUS 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 18
— — INTRAVENOUS 5
— — OPHTHALMIC 3
— — SUBCUTANEOUS 3
— — — —
— — — —

FDA drug products from Novartis Pharmaceuticals Corporation

Brand nameGenericTypeRoute
ADAKVEO CRIZANLIZUMAB HUMAN PRESCRIPTION DRUG INTRAVENOUS
Afinitor EVEROLIMUS HUMAN PRESCRIPTION DRUG ORAL
COSENTYX SECUKINUMAB HUMAN PRESCRIPTION DRUG SUBCUTANEOUS
Diovan VALSARTAN HUMAN PRESCRIPTION DRUG ORAL
EGATEN TRICLABENDAZOLE HUMAN PRESCRIPTION DRUG ORAL
ENTRESTO SACUBITRIL AND VALSARTAN HUMAN PRESCRIPTION DRUG ORAL
FABHALTA IPTACOPAN HUMAN PRESCRIPTION DRUG ORAL
Femara LETROZOLE HUMAN PRESCRIPTION DRUG ORAL
Gilenya FINGOLIMOD HCL HUMAN PRESCRIPTION DRUG ORAL
Gleevec IMATINIB MESYLATE HUMAN PRESCRIPTION DRUG ORAL
HYCAMTIN TOPOTECAN HYDROCHLORIDE HUMAN PRESCRIPTION DRUG INTRAVENOUS
Ilaris CANAKINUMAB HUMAN PRESCRIPTION DRUG SUBCUTANEOUS
KISQALI RIBOCICLIB HUMAN PRESCRIPTION DRUG ORAL
LEQVIO INCLISIRAN HUMAN PRESCRIPTION DRUG SUBCUTANEOUS
Lamprene CLOFAZIMINE HUMAN PRESCRIPTION DRUG ORAL
MAXITROL NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE HUMAN PRESCRIPTION DRUG OPHTHALMIC
MAYZENT SIPONIMOD HUMAN PRESCRIPTION DRUG ORAL
Mekinist TRAMETINIB HUMAN PRESCRIPTION DRUG ORAL
Myfortic MYCOPHENOLIC ACID HUMAN PRESCRIPTION DRUG ORAL
Neoral CYCLOSPORINE HUMAN PRESCRIPTION DRUG ORAL
PLUVICTO LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN HUMAN PRESCRIPTION DRUG INTRAVENOUS
RYDAPT RYDAPT HUMAN PRESCRIPTION DRUG ORAL
Sandimmune CYCLOSPORINE HUMAN PRESCRIPTION DRUG INTRAVENOUS
Sandostatin OCTREOTIDE ACETATE HUMAN PRESCRIPTION DRUG INTRAVENOUS
Tafinlar DABRAFENIB HUMAN PRESCRIPTION DRUG ORAL
Tegretol CARBAMAZEPINE HUMAN PRESCRIPTION DRUG ORAL
TobraDex TOBRAMYCIN AND DEXAMETHASONE HUMAN PRESCRIPTION DRUG OPHTHALMIC
Travatan Z TRAVOPROST HUMAN PRESCRIPTION DRUG OPHTHALMIC
VANRAFIA ATRASENTAN HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does Novartis Pharmaceuticals Corporation make?
29 FDA drug label records name Novartis Pharmaceuticals Corporation as the manufacturer, covering 28 distinct active ingredients.

What active ingredients does Novartis Pharmaceuticals Corporation produce?
The most frequent active ingredients in this portfolio are CYCLOSPORINE, ATRASENTAN, CANAKINUMAB, CARBAMAZEPINE, CLOFAZIMINE.

Are Novartis Pharmaceuticals Corporation products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.